Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smoking Cessation Claims For E-Cigarettes Draw FDA Warnings

This article was originally published in The Tan Sheet

Executive Summary

FDA sets ground rules for regulating electronic cigarettes in warning letters to five firms about unapproved smoking cessation claims and in a separate summary letter to an industry trade group
Advertisement

Related Content

With Deeming Rule Pending, FDA Reminds E-Cigarette Firms About Drug Claims
U.K. Packages All Electronic Cigarettes Under Medical Regulation
Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions
Tobacco Investment Means E-Cigarette Growth, But Drug Path Raises Questions
E-Cigarettes' Role In Smoking Cessation Supported By Studies
Classifying E-Cigarettes As Tobacco Snuffs Out Cessation Utility – FDA
Advisory Committee On NRT Indications Appears Likely Following Workshop
New Products In Brief
NRT Potential Smolders Around Electronic Cigarettes
NRT Potential Smolders Around Electronic Cigarettes
Advertisement
UsernamePublicRestriction

Register

PS104500

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel